Our next installment of the Research Video Series breaks down HD Buzz's latest article focusing on vitamin therapies for Huntington's Disease. A small clinical trial of high-dose biotin and thiamine for treating HD is being planned in Spain. This trial is based on research that links HD to another neurodegenerative disease called biotin-thiamine responsive basal ganglia disease (BTBGD).
Thanks to our video sponsors: uniQure, Neurocine Biosciences, Sage Therapeutics and Teva.